Filing metadata

Accession number
0001415889-24-025909
Form type
Form 3
Filer
Lyell Immunopharma, Inc.
CIK
CIK 1806952
Filed
Nov 01, 2024
Reporting period
Oct 31, 2024
Description
Initial ownership

Explore SEC Filings Hub